Bernard A Fox insider trades: Neopharm (NEOL) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Bernard reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 30, 2008 | NEOL | ↑ Buy | 4,000 | $0.61 | $2K | Direct | Jun 2, 2008 (3d) |
| Mar 21, 2005 | NEOL | ↑ Buy | 600 | $8.59 | $5K | Direct | Aug 2, 2005 (134d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Bernard A Fox's insider trades
Bernard A Fox is a director at Neopharm (NEOL). Since Mar 21, 2005, Bernard has reported 2 open-market purchases worth $8K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NEOL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.